sever
acut
respiratori
syndrom
sar
respiratori
diseas
origin
report
asia
begin
shortli
afterward
rapidli
spread
north
america
europ
threaten
diseas
scientist
area
devot
research
find
treatment
sar
cumul
evid
indic
previous
unrecogn
coronaviru
culprit
sar
also
known
process
cleav
sarscov
polyprotein
special
proteinas
socal
sar
coronaviru
main
proteinas
sarscov
pro
pro
key
step
replic
sarscov
function
import
pro
viral
life
cycl
make
attract
target
develop
drug
directli
new
diseas
accord
lockandkey
mechan
enzymolog
octapeptid
cleavabl
sar
proteinas
must
good
fit
bind
activ
site
thu
cleavabl
peptid
chemic
modif
convert
compet
inhibitor
enzym
elabor
chou
distort
key
theori
view
knowledg
kind
peptid
sequenc
cleav
pro
import
design
effect
inhibitor
pro
potenti
drug
sar
therapi
proteasesuscept
site
protein
usual
extend
octapeptid
gener
formul
p
p
p
p
p
p
p
p
scissil
bond
locat
subsit
p
p
sar
coronaviru
enzym
sever
viral
proteinas
exhibit
gln
ser
ala
gli
specif
octapeptid
avlqsgfr
select
paper
taken
paper
chou
et
al
author
done
studi
dock
octapeptid
sarscov
pro
base
threedimension
structur
sar
coronaviru
main
proteinas
obtain
anand
et
al
homolog
approach
bind
result
obtain
dock
studi
structur
bioinformat
show
octapeptid
avlqsgfr
bound
sar
proteinas
six
hydrogen
bond
crystal
structur
sarscov
pro
also
determin
later
yang
et
al
whose
result
confirm
analysi
present
studi
initi
attempt
conduct
indepth
examin
antivir
activ
octapeptid
avlqsgfr
sarsassoci
coronaviru
biochem
experiment
approach
materi
method
desir
octapeptid
avlqsgfr
assembl
manual
solidphas
synthesi
hbtu
coupl
fmocprotect
amino
acid
ntermin
fmoc
group
remov
treatment
piperidin
nmp
fmoc
amino
acid
equival
activ
addit
equimolar
amount
hbtu
hobt
diea
dilut
dmf
coupl
effici
determin
quantit
ninhydrin
assay
final
target
peptid
deprotect
cleav
resin
use
reversedphas
highperform
liquid
chromatographi
rphplc
hewlettpackard
seri
agil
palo
alto
ca
usa
gradient
increas
concentr
acetonitril
presenc
trifluoroacet
acid
analyz
peptid
mixtur
molecular
weight
octapeptid
also
test
ion
trap
mass
spectromet
lcq
deca
xp
thermo
finnigan
san
jose
ca
usa
prepar
rphplc
purif
carri
use
water
prep
lc
system
water
associ
milford
usa
link
deltapak
tm
semiprepar
column
mm
mm
mm
use
linear
gradient
min
acetonitriletrifluoroacet
acid
vv
flow
rate
ml
min
separ
target
peptid
uv
absorb
monitor
nm
desir
product
final
pool
freezedri
toxic
octapeptid
vero
cell
assess
antivir
activ
measur
sar
coronaviru
strain
isol
sar
patient
beij
china
cytopathogen
induc
viru
h
infect
micropl
confluent
layer
vero
cell
visual
score
select
index
determin
ratio
concentr
octapeptid
reduc
cell
viabil
cc
concentr
octapeptid
need
inhibit
cytopath
effect
control
valu
ec
cytotox
peptid
determin
mt
nonradioact
cell
prolifer
assay
kit
promega
madison
wi
usa
excel
result
obtain
solidphas
methodolog
use
fmochbtu
chemistri
crude
avlqsgfr
show
yield
greater
puriti
molecular
weight
exactli
match
theoret
valu
yield
capac
purif
process
reach
mg
per
circl
puriti
desir
octapeptid
octapeptid
avlqsgfr
synthes
studi
toxic
vero
cell
within
experiment
concentr
shown
fig
also
recogniz
effect
vero
cell
observ
help
microscop
also
shown
fig
inhibitori
effect
octapeptid
sar
coronaviru
vero
cell
dosedepend
cultur
absorb
nm
measur
use
plate
elisa
reader
cc
ec
determin
comput
program
prizm
octapeptid
ec
mg
l
select
index
tabl
also
detect
effect
octapeptid
avlqsgfr
replic
sarsassoci
coronaviru
vero
cell
fig
observ
infect
cell
treat
mg
l
octapeptid
avlqsgfr
obvious
block
replic
viru
molecular
mechan
octapeptid
inhibit
activ
sarscov
may
illumin
bind
mechan
enzym
sarscov
pro
ligand
point
chou
et
al
six
hydrogen
bond
form
octapeptid
avlqsgfr
sarscov
pro
residu
involv
form
hydrogen
bond
enzym
interact
strong
octapeptid
natur
becom
ideal
competit
inhibitor
sar
proteinas
accordingli
result
obtain
biochem
experi
fulli
consist
comput
dock
studi
perform
chou
et
al
furthermor
result
also
compat
cinatl
et
al
assess
antivir
potenti
ribavirin
pyrazofurin
mycophenol
acid
glycyrrhizin
two
sar
coronaviru
strain
isol
germani
patient
ec
avlqsgfr
record
show
lowest
concentr
among
exist
compound
higher
select
antivir
activ
si
sarscov
suggest
avlqsgfr
serv
start
entiti
cours
discov
effect
drug
candid
treatment
sar
